Kestra Advisory Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $305K | Buy |
11,065
+4,492
| +68% | +$124K | ﹤0.01% | 2329 |
|
|
2025
Q1 | $186K | Sell |
6,573
-3,533
| -35% | -$100K | ﹤0.01% | 2494 |
|
|
2024
Q4 | $420K | Buy |
10,106
+1,269
| +14% | +$52.8K | ﹤0.01% | 1983 |
|
|
2024
Q3 | $591K | Sell |
8,837
-2,469
| -22% | -$165K | ﹤0.01% | 1660 |
|
|
2024
Q2 | $1.34M | Sell |
11,306
-934
| -8% | -$111K | 0.01% | 1160 |
|
|
2024
Q1 | $1.3M | Sell |
12,240
-1,804
| -13% | -$192K | 0.01% | 1087 |
|
|
2023
Q4 | $1.4M | Sell |
14,044
-7,284
| -34% | -$724K | 0.01% | 963 |
|
|
2023
Q3 | $2.2M | Buy |
21,328
+8,696
| +69% | +$898K | 0.02% | 653 |
|
|
2023
Q2 | $1.53M | Sell |
12,632
-1,872
| -13% | -$227K | 0.02% | 782 |
|
|
2023
Q1 | $2.23M | Sell |
14,504
-1,933
| -12% | -$297K | 0.02% | 610 |
|
|
2022
Q4 | $2.95M | Sell |
16,437
-203
| -1% | -$36.5K | 0.03% | 603 |
|
|
2022
Q3 | $1.97M | Sell |
16,640
-362
| -2% | -$42.8K | 0.02% | 669 |
|
|
2022
Q2 | $2.43M | Sell |
17,002
-3,112
| -15% | -$445K | 0.03% | 602 |
|
|
2022
Q1 | $3.47M | Buy |
20,114
+2,541
| +14% | +$438K | 0.04% | 482 |
|
|
2021
Q4 | $4.46M | Sell |
17,573
-9,888
| -36% | -$2.51M | 0.05% | 409 |
|
|
2021
Q3 | $10.6M | Buy |
27,461
+5,531
| +25% | +$2.13M | 0.11% | 211 |
|
|
2021
Q2 | $5.15M | Sell |
21,930
-4,754
| -18% | -$1.12M | 0.06% | 354 |
|
|
2021
Q1 | $3.49M | Sell |
26,684
-3,655
| -12% | -$479K | 0.04% | 420 |
|
|
2020
Q4 | $3.37M | Buy |
30,339
+13,017
| +75% | +$1.45M | 0.04% | 431 |
|
|
2020
Q3 | $1.23M | Buy |
+17,322
| New | +$1.23M | 0.02% | 559 |
|